SOUTH SAN FRANCISCO, Calif.,
Feb. 1, 2022 /PRNewswire/
-- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic
lethality focused precision medicine oncology company committed to
the discovery and development of targeted therapeutics, announced
its participation in an investor conference in February 2022.
Guggenheim Oncology Day
Wednesday, February 9, 2022 at
3:30pm ET
Fireside chat with Yujiro Hata, Chief Executive Officer, hosted
by Charles Zhu, Ph.D. Vice President, Biotechnology Equity
Research
A live audio webcast of the event will be available, as
permitted by conference host, at the "Investors/News and
Events/Investor Calendar" section of the IDEAYA website at
https://ir.ideayabio.com/events. A replay of available
webcasts will be accessible for 30 days following the live
event.
About IDEAYA Biosciences
IDEAYA is a synthetic
lethality-focused precision medicine oncology company committed to
the discovery and development of targeted therapeutics for patient
populations selected using molecular diagnostics. IDEAYA's
approach integrates capabilities in identifying and validating
translational biomarkers with drug discovery to select patient
populations most likely to benefit from its targeted
therapies. IDEAYA is applying its early research and drug
discovery capabilities to synthetic lethality – which represents an
emerging class of precision medicine targets.
Forward-Looking Statements
This press release contains
forward-looking statements, including, but not limited to,
statements related to participation in and/or presentation at
certain investor relations events. IDEAYA undertakes no obligation
to update or revise any forward-looking statements. For a further
description of the risks and uncertainties that could cause actual
results to differ from those expressed in these forward-looking
statements, as well as risks relating to the business of IDEAYA in
general, see IDEAYA's Quarterly Report on Form 10-Q filed on
November 15, 2021 and any current and
periodic reports filed with the U.S. Securities and Exchange
Commission.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-investor-conferences-in-february-2022-301470853.html
SOURCE IDEAYA Biosciences, Inc.